首页|卵巢恶性混合性生殖细胞肿瘤9例临床分析

卵巢恶性混合性生殖细胞肿瘤9例临床分析

扫码查看
目的 分析卵巢恶性混合性生殖细胞肿瘤(OMMGCT)患者临床资料,探讨其临床表现、病理特征及预后。方法 2010年1月-2020年12月河南省人民医院诊治OMMGCT患者9例,收集临床资料,包括发病年龄、临床症状、术前血清肿瘤标志物水平,肿瘤侧别、最大直径、性质,病理分期及类型,手术方式、化疗方案及预后情况。结果 9例患者发病年龄6~59岁,中位年龄19岁。临床症状均为腹痛,伴腹胀3例,伴发热1例。术前血清甲胎蛋白水平均升高、人绒毛膜促性腺激素、糖类抗原125、糖类抗原19-9水平正常或升高。肿瘤均为单侧,其中左侧2例,右侧7例;肿瘤最大直径5~19 cm;肿瘤性质为实性或囊实性。9例患者病理分期Ⅰ期7例,Ⅱ期2例。病理类型包含2~4种成分,其中包含2种成分7例,3种成分1例,4种成分1例;以卵黄囊瘤成分为主7例。9例患者均行手术治疗,其中保留生育功能手术7例,全面分期手术2例;术后均行化疗,其中博莱霉素+依托泊苷+顺铂(BEP)方案6例,顺铂+长春新碱+博来霉素(PVB)方案2例,长春新碱+放线菌素+环磷酰胺(VAC)方案1例。治疗后随访18~33个月,1例Ⅱ期患者术后2年复发,行二次手术治疗(子宫+右侧附件切除术),术后给予BEP方案化疗6个疗程,现患者存活;余8例随访结束时无复发。结论 OMMGCT多发生于年轻女性,常见临床症状为腹痛,血清甲胎蛋白水平不同程度增高;肿块较大、多为单侧,病理类型多样,可含2~4种成分,以卵黄囊瘤多见;病理分期Ⅰ~Ⅱ期者可采取保留生育功能手术联合术后化疗(常用BEP方案)治疗,近期预后较好。
Clinical analysis of malignant germ cell tumors of the ovary in 9 cases
Objective To analyze the clinical data of patients with malignant germ cell tumors of the ovary(OMMGCT),and to explore their clinical manifestations,pathological features and prognosis.Methods Nine patients with OMMGCT were diagnosed and treated in Henan Provincial People's Hospital from January,2010 to December,2020,and their clinical data were collected,including the age of onset,clinical symptoms,preoperative serum tumor markers,side of the tumor,maximal diameter,nature,pathological stage and type,surgical modality,chemotherapeutic regimen and prognosis.Results Nine patients had an age of onset of 6 to 59 years old,with a median age of 19 years old.The clinical symptoms included abdominal pain in 9 patients,abdominal distension in 3 and fever in 1.The preoperative serum alpha fetoprotein levels were elevated,and the levels of human chorionic gonadotropin,carbohydrate antigen 125,and carbohydrate antigen 19-9 were normal or elevated.The tumors were unilateral in all patients,including 2 cases of OMMGCT on the left side and 7 cases on the right side.The maximal diameter was 5 to 19 cm.The nature of the OMMGCT was solid or cystic solid.The pathological stage was stage Ⅰ in 7 patients and stage Ⅱ in 2.The pathological type contained 2 to 4 components,including 2 components in 7 patients,3 components in 1,and 4 components in 1.Seven patients were found predominantly yolk sac tumor components.All 9 patients underwent surgical treatment,including fertility-preserving surgery in 7 patients and fully staged surgery in 2.All of them received chemotherapy after surgery,including bleomycin+etoposide+cisplatin(BEP)regimen in 6 patients,bleomycin+cisplatin+vincristine regimen in 2,and vincristine+actinomycin+cyclophosphamide regimen in 1.The follow-up after the comprehensive treatment was conducted for 18 to 33 months.One patient in stage Ⅱ underwent a second surgical treatment(hysterectomy+right adnexectomy)2 years after surgery due to recurrence,followed by 6 courses of chemotherapy with the BEP regimen,and she is still alive.The other 8 patients had no recurrence at the end of follow-up.Conclusions OMMGCT occur mostly in young women,with the common clinical symptom of abdominal pain,elevated serum alpha fetoprotein level in different degrees.The mass is usually large,mostly unilateral,in various pathological types,containing 2 to 4 components,mostly yolk cystic tumors.Those with pathological stage of Ⅰ to Ⅱ can choose fertility-preserving surgery followed by chemotherapy(BEP regimen).The short-term prognosis is generally good.

malignant germ cell tumors of the ovaryalpha fetoproteinfertility-preserving surgerychemotherapyBEP regimen

李辉、刘伟娜、王悦、冯燕、范盼红、陈小辉

展开 >

河南省人民医院 郑州大学人民医院妇科,河南郑州 450003

郑州大学第二附属医院妇科,河南郑州 450014

河南省人民医院 郑州大学人民医院病理科,河南郑州 450003

卵巢恶性混合性生殖细胞肿瘤 甲胎蛋白 保留生育功能手术 化疗 BEP方案

国家自然科学基金

82072883

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(6)